Asia-Pacific Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others
Summary
GlobalData’s “Asia-Pacific Orthobiologics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Asia-Pacific Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Orthobiologics, Cartilage Repair and Others
The Asia-Pacific Orthobiologics Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Orthobiologics Market.
Global corporate-level profiles of key companies operating within the Asia-Pacific Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
Asia-Pacific Orthobiologics is segmented as follows -
Bone Grafts and Substitutes
Bone Growth Stimulators
Cartilage Repair
Soft Tissue Biologics
Viscosupplementation
Reasons to Buy
The Asia-Pacific Orthobiologics Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
7.2.5 Viscosupplementation Market, Japan, Volume (Units), by Segment, 2018-2033
7.3 Orthobiologics Market, Japan, Average Price ($) , 2018-2033
7.4 Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2023
7.5 Orthobiologics Market, Japan, Company Share by Revenue ($m), 2023
8 Orthobiologics Market, South Korea
8.1 Orthobiologics Market, South Korea, Revenue ($m), 2018-2033
8.1.1 Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.1.2 Bone Growth Stimulators Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.1.3 Cartilage Repair Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.1.4 Soft Tissue Biologics Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.1.5 Viscosupplementation Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.2 Orthobiologics Market, South Korea, Volume (Units), 2018-2033
8.2.1 Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2018-2033
8.2.2 Bone Growth Stimulators Market, South Korea, Volume (Units), by Segment, 2018-2033
8.2.3 Cartilage Repair Market, South Korea, Volume (Units), by Segment, 2018-2033
8.2.4 Soft Tissue Biologics Market, South Korea, Volume (Units), by Segment, 2018-2033
8.2.5 Viscosupplementation Market, South Korea, Volume (Units), by Segment, 2018-2033
8.3 Orthobiologics Market, South Korea, Average Price ($) , 2018-2033
8.4 Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), 2023
8.5 Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2023
9 Overview of Key Companies in Asia-Pacific Orthobiologics Market
9.1 Sanofi
9.1.1 Company Overview
9.2 Medtronic Plc
9.2.1 Company Overview
9.3 Stryker Corp
9.3.1 Company Overview
9.4 Seikagaku Corp
9.4.1 Company Overview
9.5 Zimmer Biomet Holdings Inc
9.5.1 Company Overview
9.6 Smith & Nephew Plc
9.6.1 Company Overview
10 Orthobiologics Market Pipeline Products
11 Recent Developments
11.1 Financial Announcements
11.1.1 Dec 20, 2023: Significant Health & Quality of Life Improvements Achieved in Children with Achondroplasia Treated for One Year with TransCon CNP at 100 µg/kg/week